###
中国临床研究英文版:2026,39(9):1350-1355
本文二维码信息
码上扫一扫!
基于Monaco治疗计划系统的内切等中心调强放疗在乳腺癌术后放射治疗中的应用
(安徽第二医学院附属医院安庆一一六医院胸部肿瘤科,安徽 安庆 246003)
Application of Iniso-IMRT in Monaco intensity-modulated radiotherapy for radiotherapy patients after breast cancer surgery
(Department of Thoracic Oncology,Anqing 116 Hospital,Affiliated Hospital of Anhui Institute of Medicine,Anqing,Anhui 246003,China)
摘要
本文已被:浏览 157次   下载 161次
Received:May 26, 2026   Published Online:September 24, 2026
中文摘要: 目的  探讨Monaco 调强放疗计划(IMRT)中内切等中心调强放疗计划(Iniso-IMRT 计划)在乳腺癌术后放射治疗(放疗)患者中的应用效果。方法  选取2023 年1 月至2025 年12 月安庆一一六医院收治的乳腺癌术后放疗患者80 例,采用自身对照设计,对每例患者基于同一套定位CT 图像,在Monaco 治疗计划系统中分别设计常规IMRT 计划(常规IMRT 组)与Iniso-IMRT 计划(Iniso-IMRT 组),两组计划采用相同射野设置、处方剂量及剂量归一方式,比较两组计划靶区剂量学参数[D95%、D98%、D2%、靶区平均剂量(Dmean)、V100%、V95%、V110%、适形指数、均匀性指数]、危及器官剂量学参数[心脏:V5Gy、V10Gy、V20Gy、V30Gy、V40Gy及Dmean;患侧肺:V5Gy、V10Gy、V20Gy、V30Gy、V40Gy、Dmean及最大剂量(Dmax);对侧肺:V5Gy及Dmean;对侧乳腺:Dmean;脊髓:Dmax;皮肤:Dmax及Dmean]、计划效率参数(计划优化时间、机器跳数)以及剂量验证结果(γ通过率、绝对剂量偏差)。结果  Iniso-IMRT组适形指数高于常规IMRT组且更接近于1,均匀性指数低于常规IMRT组(P<0.01);Iniso-IMRT组与常规IMRT组放疗计划靶区剂量体积参数D95%、D98%、D2%、Dmean、V100%、V95%及V110%比较,差异均无统计学意义(P>0.05);危及器官方面,Iniso-IMRT组心脏各剂量学参数及左侧乳腺癌亚组心脏各参数均低于常规IMRT 组(P<0.05);患侧肺V20Gy、V30Gy、V40Gy、Dmean及Dmax均低于常规IMRT组(P<0.05),而两组V5Gy、V10Gy差异无统计学意义(P>0.05);对侧肺、对侧乳腺、脊髓及皮肤各参数两组间差异均无统计学意义(P>0.05)。Iniso-IMRT 组计划优化时间短于常规IMRT 组,机器跳数低于常规IMRT 组,γ通过率高于常规IMRT组(P<0.05)。结论  相较于常规IMRT计划,Iniso-IMRT计划在维持靶区等效剂量覆盖的前提下,提高了靶区剂量分布适形度与均匀性,降低了心脏及患侧肺中高剂量区受照体积,减少了机器跳数,缩短了计划优化时间,提高了剂量验证γ通过率。
Abstract:Objective To investigate the application effect of inner tangent isocenter- intensity-modulated radiotherapy(Iniso-IMRT)in Monaco intensity-modulated radiotherapy(IMRT)for radiotherapy patients after breast cancer surgery.Methods A total of 80 patients undergoing radiotherapy after breast cancer surgery in the hospital were enrolled between January 2023 and December 2025. In the self-controlled design,the same set of CT positioning images were applied in each patient. In Monaco treatment plan system,routine IMRT plan(routine IMRT group)and Iniso-IMRT plan(Iniso - IMRT group)were designed. There were the same radiation field setting,prescription dose and dose normalization method in the two groups. The dosimetry parameters of planning target volume[D95%,D98%,D2%,mean target dose(Dmean),V100%,V95%,V110%,conformal index,homogeneity index],dosimetry parameters of organs at risk[heart:V5Gy,V10Gy,V20Gy,V30Gy,V40Gy,Dmean;lung at affected side:V5Gy,V10Gy,V20Gy,V30Gy,V40Gy,Dmean,maximum dose(Dmax);contralateral lung:V5Gy,Dmean;contralateral breast:Dmean;spinal cord:Dmax;skin:Dmax,Dmean],planning efficiency parameters(planned optimization time,monitor unit)and dose validation results(γ pass rate,absolute dose deviation)were compared between the two groups. Results Conformal index in Iniso-IMRT group was greater than that in routine IMRT group,which was closer to 1,while homogeneity index was lower than that in routine IMRT group(P<0.01). The difference in dosimetry parameters of planning target volume(D95%,D98%,D2%,Dmean,V100%,V95%,V110%)was not statistically significant between the two groups(P>0.05). In terms of organs at risk,dosimetry parameters of heart in Iniso-IMRT group and cardiac parameters in left breast cancer subgroup were lower than those in routine IMRT group(P<0.05). V20Gy,V30Gy,V40Gy,Dmean and Dmax of affected lung in Iniso-IMRT group were lower than those in routine IMRT group (P<0.05),but there was no significant difference in V5Gy or V10Gy between the two groups (P>0.05). The parameters of contralateral lung,contralateral breast,spinal cord and skin in the two groups were similar(P>0.05).Compared with routine IMRT group,planned optimization time was shorter,monitor unit was lower,and γ pass rate was higher in Iniso-IMRT group(P<0.05). Conclusion Compared with routine IMRT plan,Iniso-IMRT can improve conformity and homogeneity of target dose distribution while maintaining equivalent dose coverage of target volume,reduce irradiation volume of middle-dose and high-dose areas in heart and lung at affected side,reduce monitor unit,shorten planned optimization time and increase γ passing rate of dose validation.
文章编号:     中图分类号:R737.9 R730.55    文献标志码:A
基金项目:吴阶平医学基金会临床科研专项资助基金项目(320.6750.2024-19-19)
引用文本:


Scan with WeChat

Scan with WeChat